Exercise Can Reduce Arterial Stiffness—With One Big Caveat

Exercise helps stiff arteries—unless obesity changes the equation

Aerobic exercise can reduce arterial stiffness in many older adults. But one randomized trial found that the same disciplined exercise program did not measurably improve proximal aortic stiffness in older adults with obesity. In that group, exercise paired with moderate caloric restriction improved aortic distensibility; exercise alone did not.

This distinction matters because arterial stiffness is more than an inconvenient blood-pressure-adjacent metric. Carotid-femoral pulse wave velocity (cfPWV), a standard measure of aortic stiffness, predicts cardiovascular events and mortality independently of conventional risk factors. It is still a surrogate outcome, though: current exercise trials do not establish that lowering PWV by a given amount prevents a given number of heart attacks or deaths.

The practical message is narrower than the usual "exercise fixes everything" pitch. Exercise remains an excellent cardiovascular intervention. Its effect on arterial stiffness appears to depend on the population, the vessel measured, and—in older adults with obesity—whether the intervention also reduces adiposity without using an aggressive calorie deficit.

Why a stiff aorta matters

With each heartbeat, the aorta should expand and recoil. As its wall stiffens, pressure waves travel faster and the heart faces a less forgiving circulation. Higher PWV has repeatedly tracked with worse outcomes. A 2024 cohort study linked metabolomic patterns associated with aortic stiffness to future coronary artery disease and all-cause mortality over 23 years of follow-up. In chronic kidney disease, a study of 181 patients found that PWV added prognostic information for kidney-disease progression and cardiovascular events beyond albuminuria.

Associations do not prove that stiffness itself causes every downstream event. They do establish that a stiffer aorta is a serious risk marker, not a cosmetic number for a wellness dashboard. A Sardinian cohort study also found that GDF-15, an age-associated biomarker, correlated with cfPWV and predicted all-cause mortality. That supports a link between arterial stiffening and biological aging, but it does not show that changing GDF-15 or PWV will automatically change mortality.

For non-obese older adults, aerobic training has consistent support

A 2026 systematic review of randomized trials in adults 65 and older found that aerobic training reduced PWV by roughly 0.62 to 0.85 m/s in non-obese populations. The review proposed several plausible contributors: improved endothelial nitric oxide signaling, less oxidative stress and chronic inflammation, reduced sympathetic nervous-system activity, and favorable remodeling of collagen and elastin in the arterial wall.

The available evidence does not crown one exercise style. A 2025 meta-analysis of randomized trials found that both high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) significantly reduced arterial stiffness in adults, without a clearly superior modality. For most people, the best protocol is therefore the one they can perform consistently and safely, rather than the one with the most intimidating acronym.

Adding resistance training to aerobic work may produce a modest additional improvement in older adults, according to the 2026 review. The evidence is limited by small trials and varied protocols, so it does not justify treating concurrent training as a guaranteed upgrade. Resistance training still has obvious reasons to belong in an older adult's program, including maintaining strength and lean mass.

Exercise also affects pathways that can matter when cardiovascular risk is high. In a 12-week randomized trial in sedentary older adults with chronic kidney disease, cycling three days per week improved sympathetic activity and vascular measures compared with time-matched stretching. In a separate resistant-hypertension trial, 12 weeks of aerobic exercise reduced central systolic blood pressure by 12.22 mm Hg (95% CI, −22.57 to −1.88) and blood-pressure variability by 2.85 mm Hg (95% CI, −4.91 to −0.78). Those results support exercise for cardiovascular health, but they do not erase the obesity-specific aortic finding below.

The trial that complicates the standard prescription

The key exception comes from a 2022 Circulation randomized controlled trial led by Tina Brinkley and colleagues. The study included 160 adults with cardiovascular MRI data, ages 65 to 79, with body-mass indexes of 30 to 45. Over 20 weeks, participants completed one of four interventions: supervised treadmill exercise alone; exercise plus moderate caloric restriction; exercise plus high caloric restriction; or caloric restriction alone.

The exercise prescription was real exercise, not a politely worded suggestion: treadmill walking four days a week at 65% to 75% of heart-rate reserve. Yet the exercise-only group, 56 participants, had no significant improvement in aortic arch PWV or aortic distensibility measured by cardiovascular MRI.

That endpoint matters. Unlike surface PWV measures, the trial assessed the proximal aorta directly with MRI, including the aortic arch and distensibility. Its result does not prove that exercise has no vascular benefit in every older person with obesity. It does show that 20 weeks of supervised aerobic training alone failed to improve these specific aortic measures in this population.

Adding a moderate calorie deficit changed the result. The exercise-plus-moderate-restriction group, 49 participants, targeted a deficit of about 250 kcal per day and significantly improved distensibility in both the ascending and descending aorta. The exercise-plus-high-restriction group, 55 participants, targeted about 600 kcal per day, lost more weight, and did not improve distensibility. More weight loss did not produce more improvement in this endpoint.

The study also measured periaortic adipose tissue. Changes in that fat depot correlated with changes in aortic distensibility in the weight-loss groups. This is consistent with the idea that tissue surrounding the vessel may modify aortic function. A correlation, however, does not prove that periaortic fat caused the change or identify the exact biological pathway.

Why obesity may blunt the response

Obesity can bring persistent low-grade inflammation, oxidative stress, and reduced nitric oxide bioavailability—conditions that could make arteries less responsive to exercise. These are plausible explanations, not individually proven causes of the null exercise result in the Brinkley trial.

AGE-related collagen cross-linking is another proposed explanation for structurally less flexible arteries. The evidence needs restraint here. A 2025 Maastricht Study found that circulating reactive dicarbonyls, precursors involved in AGE biology, were not independently associated with arterial stiffness after adjustment for confounders. That result does not rule out structural cross-linking within the arterial wall, but it weakens any simple claim that a blood marker of dicarbonyl exposure explains exercise-resistant stiffness.

The high-calorie-restriction result also remains unexplained. Greater lean-mass loss or counter-regulatory changes in vascular tone are possible hypotheses, but the trial did not verify either mechanism. Older adults should not infer that a 600-kcal deficit is inherently harmful; they should infer that this one trial did not find a linear dose-response for aortic distensibility.

Why the broader exercise literature does not settle the disagreement

The HIIT-versus-MICT meta-analysis included overweight and obese participants and found PWV reductions with both exercise approaches. That partly conflicts with the MRI trial. The studies are not interchangeable: the meta-analysis did not isolate adults 65 and older with BMI of at least 30, and most included studies used cfPWV or brachial-ankle PWV rather than MRI measures of the aortic arch. Different populations, vessels, and methods can produce different answers.

The Brinkley trial is also one study from one center, with 20 weeks of follow-up. Its moderate-restriction benefit and high-restriction null result need independent replication, preferably in longer trials. Several MRI outcomes were tested without an explicitly reported adjustment for multiple comparisons, which raises the chance that some positive findings occurred by chance.

Dietary options for postmenopausal women

Menopause reduces nitric oxide bioavailability, a change that may contribute to arterial stiffening. In a double-blind, placebo-controlled 12-week trial, 20 postmenopausal women ages 60 to 85 received either nitrate-rich or nitrate-depleted beetroot extract. The nitrate-rich group received 8.8 mmol per day. The trial found improved carotid arterial stiffness with dietary nitrate. It tested carotid measures, not aortic MRI measures or cardiovascular events, and its small sample means the result needs confirmation.

A meta-analysis of eight randomized trials also found that soy isoflavone supplementation reduced arterial stiffness overall, with much of the effect coming from postmenopausal women. Trial results varied substantially, so the analysis does not identify a universal dose or guarantee that every postmenopausal woman will respond. Nitrate and soy are additions to a broader exercise and dietary pattern, not substitutes for one.

One subgroup deserves special caution: overweight or obese postmenopausal women with low lean mass. A cross-sectional study linked lower limb lean mass with higher brachial-ankle PWV and less favorable pulse-wave measures in this group. The design cannot show that rebuilding lean mass will reverse stiffness, but it gives resistance training a stronger rationale than calorie restriction alone when sarcopenia is part of the picture.

What to do with this evidence

• Non-obese older adults: Choose aerobic exercise that you can sustain. HIIT and MICT both have randomized-trial support for lower arterial stiffness; adding resistance training may add a modest benefit.
• Older adults with obesity: Do not assume aerobic exercise alone will improve proximal aortic stiffness. The best direct evidence supports supervised exercise combined with moderate caloric restriction, but it comes from a single 20-week trial and needs replication.
• Postmenopausal women: Dietary nitrate and soy isoflavones have trial evidence for stiffness-related outcomes, but the evidence is short-term or heterogeneous. Discuss supplements, medications, blood pressure, and kidney disease with a clinician before making them routine.
• People with obesity and low lean mass: Prioritize preserving or building muscle while pursuing weight management. The vascular benefit of that strategy remains untested in a dedicated randomized trial.

Exercise is still the foundation. The evidence simply argues against pretending that every artery, every body composition, and every calorie deficit responds the same way.

The unanswered clinical question is the largest one: whether the roughly 0.62 to 0.85 m/s PWV reductions seen with exercise translate into a measurable reduction in mortality risk. Existing evidence makes arterial stiffness worth targeting. It does not yet supply a precise mortality threshold for an individual reader.